SubHero Banner
Text

January 2025

Core topics in this month’s edition include:

  • Journavx™ (suzetrigine)  – New drug approval
  • Fentanyl Transdermal System 25 mcg patches - Drug recall 
  • Ozempic® (semaglutide)  - New indication

Download

Text